Novo Nordisk Pharma GmbH secures contract for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient concizumab (Alhemo(r))

Germany, Sept. 29 -- Germany based Novo Nordisk Pharma GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient concizumab (Alhemo(r)). The value of the contract is worth 216000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....